p-Index From 2020 - 2025
10.704
P-Index
This Author published in this journals
All Journal International Journal of Public Health Science (IJPHS) SAINS MEDIKA : JURNAL KEDOKTERAN DAN KESEHATAN Jurnal Ilmiah Farmasi Jurnal Kebijakan Kesehatan Indonesia Pharmaciana: Jurnal Kefarmasian Indonesian Journal of Pharmaceutical Science and Technology Jurnal Farmasi Klinik Indonesia Jurnal Ilmu Farmasi dan Farmasi Klinik (Journal of Pharmaceutical Science and Clinical Pharmacy) Pharmacon MPI (Media Pharmaceutica Indonesiana) INDONESIAN JOURNAL OF PHARMACY Acta Pharmaceutica Indonesia UNEJ e-Proceeding Journal of Islamic Pharmacy JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA The Indonesian Biomedical Journal Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Jurnal Penelitian Kesehatan Suara Forikes Jurnal Surya Medika Jurnal Wiyata : Penelitian Sains dan Kesehatan JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Majalah Farmaseutik Jurnal Ilmiah Manuntung Pharmasipha Jurnal Farmasi Medica (Pharmacy Medical Journal) PMJ Media Ilmu Kesehatan JSFK (Jurnal Sains Farmasi & Klinis) JFL : Jurnal Farmasi Lampung JPSCR : Journal of Pharmaceutical Science and Clinical Research PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Jurnal Endurance: Kajian Ilmiah Problema Kesehatan Jurnal Farmasi Indonesia Oceana Biomedicina Journal JFIOnline JURNAL MEDIA KESEHATAN PREPOTIF : Jurnal Kesehatan Masyarakat Jurnal Aisyah : Jurnal Ilmu Kesehatan Journal of Pharmaceutical and Health Research Jurnal Insan Farmasi Indonesia Jurnal Farmasi dan Sains Indonesia (JFSI) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Media Farmasi Indonesia Jurnal Farmasi Sains dan Praktis Jurnal Ilmiah Kesmas-IJ (Indonesia Jaya) Riset Informasi Kesehatan Journal of Health Economic and Policy Research (JHEPR) Academic Hospital Journal Kartika : Jurnal Ilmiah Farmasi Jurnal Ilmiah Multidisiplin Keilmuan Mandira Cendikia (JIMK-MC) Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan Indonesian Journal of Pharmacology and Therapy Strada Jurnal Ilmiah Kesehatan (SJIK)
Claim Missing Document
Check
Articles

Economic evaluation of antibiotic usage for cesarean section in PKU Muhammadiyah Yogyakarta Hospital Tri Murti Andayani; Riswaka Sudjaswadi
Indonesian Journal of Pharmacy Vol 16 No 2, 2005
Publisher : Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, Skip Utara, 55281, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (163.18 KB) | DOI: 10.14499/indonesianjpharm0iss0pp70-75

Abstract

In the developed countries, the incidence of cesarean section year by year increases by 7 –10 %. There have been various kinds of cesarean section in several hospitals. In PKU Muhammadiyah Yogyakarta hospital, the incidence of cesarean section in 2001 increased up to 21 %. There are also various kinds of antibiotics used to deal with cesarean section cases which caused various kinds of medical cost. Therefore, identification of antibiotics cost, which used to deal with cesarean section in PKU Muhammadiyah Yogyakarta hospital was studied.The study was performed by epidemiological survey of cesarean section via patient’s medical record, medicinal cost for treatment and surgery, and patient’s invoice in the year 2000. The study involved recording identification of patients and physicians identities, antibiotics and other medicines used, surgical equipment, cesarean section indications, pharmacy and other cost, duration of staying related to cesarean section.Results showed that the majority of cesarean section has prolonged labour (26%). The majority of antibiotics used in cesarean section is Sulbenicillin injection with Klindamicin oral (31%) and Amoxicillin/potassium clavulanate injection with Amoxicillin oral (23%). Cost of antibiotics were 12.5% - 44.4% of pharmacy expenses and 6.7% - 14.8% of total expenses. No correlation between antibiotics cost and hospital stays.Key words : cost, antibiotic, cesarean section
The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients Tri Murti Andayani; Mohamed Izham Mohamed Ibrahim; Ahmad H. Asdie
Indonesian Journal of Pharmacy Vol 20 No 4, 2009
Publisher : Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, Skip Utara, 55281, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (280.756 KB) | DOI: 10.14499/indonesianjpharm0iss0pp224-230

Abstract

Diabetes mellitus is a complex disorder that involves multiple pathophysiological defects. As the disease progresses, further functional decline in β-cell is apparent. In most cases, patients on oral antidiabetic therapy will require not only an increase in dose, but also the addition of a second or third oral agent. The aim of this study was to evaluate the effectiveness and safety of triple therapy with sulfonylurea, metformin, and acarbose in patients with poorly controlled glycemia. The study design was a prospective observational study in 49 type 2 diabetic patients followed in Department of Endocrinology RSUP Dr Sardjito Indonesia from May 2007 to September 2008. Patients with hypertension were included if their blood pressure was well controlled with antihypertensive medication. All patients with documented gastrointestinal disease were excluded. At baseline and at 3-month intervals, levels of HbA1C, fasting and postprandial plasma glucose, hypoglycemic episodes, and edverse event were evaluated. Fourty nine patients, 22 men and 27 women, aged 62.84 +7.85 years, diabetes duration of 11.92 +6.09 years were studied. The initial HbA1C level was 8.08 +1.89 % which significantly increased to 8.73 +2.37 % (p<0.05). Only 32.98 % of subjects achieved target value of HbA1C (≤ 7 %). Fasting and post-prandrial plasma glucose values were increased from 160.39 +60.25 mg/dL to 170.71+56.60 mg/dL and 210.31+ 75.88 mg/dL to 218.67 +75.03 mg/dL respectively, but not significantly different. Acarbose was more frequently associated with flatulence (46 %) and abdominal bloating (12 %), metformin with flatulence (12 %), nausea (14 %), diarrhea (2 %) and abdominal discomfort (6 %). In conclusion, combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetic patients with poorly controlled glycemia can cause the additive risk of adverse events.Key words : triple therapy, glycemic control, type 2 diabetes mellitus
Cost-minimization analysis of intravenous sulbenicillin versus coamoxiclav for cesarean section Tri Murti Andayani; Umi Athijah; Ali Ghufron Mukti
Indonesian Journal of Pharmacy Vol 15 No 4, 2004
Publisher : Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, Skip Utara, 55281, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (209.17 KB) | DOI: 10.14499/indonesianjpharm0iss0pp201-206

Abstract

The cost of antibiotic prophylaxis sulbenicillin versus coamoxiclav (in term of medication use and treatment of complications) to treat cesarean section was compared.The medical records of patient receiving intravenous sulbenicillin orcoamoxiclav for the treatment of cesarean section in PKU Muhammadiyah Hospital were retrospectively reviewed. Data were collected for patients treated from January 1, 2000 to December 31, 2000. Patient data collected included patient data based, indication of cesarean section, abdominal incision and oral antibiotics. Cost data collected included drug acquisition cost, cost of drug supplies, nursing time to administer the agents and cost of managing complication.The medical records of 98 patients were identified and reviewed. The average length of stay was 4.85 days for the sulbenicillin group and 4.90days for the coamoxiclav group. The average total including the cost of complication was Rp. 140.509 in sulbenicillin group and Rp. 376.310 in coamoxiclav group.In conclusion, the study demonstrates that intravenous coamoxiclav has a higher cost than that of intravenous sulbenicillin. This result can be used to assist institution, clinicians and pharmacists in determining the most appropriate and efficient use of drugs. These data can be a powerful tool to support various clinical and policy drug use decisions, for example included formulary management and drug use policy or guidelines.Key words: antibiotics, cesarean section, cost.
The Off-Label Use of Oxcarbazepine In Indonesia Bangunawati Rahajeng; Zullies Ikawati; Tri Murti Andayani; Iwan Dwiprahasto
Acta Pharmaceutica Indonesia Vol. 43 No. 1 (2018)
Publisher : School of Pharmacy Institut Teknologi Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Oxcarbazepine is a second-generation anticonvulsant drug that is a keto analog of carbamazepine. Oxcarbazepine was approved by The National Agency of Drug and Food Control Indonesia (NA-DFC) for generalized epilepsy, tonic-clonic primary and partial epilepsy with or without secondary generalization. However, as other anticonvulsants, oxcarbazepine is also often used without approved indication (off-label). The aim of this study is to investigate the off-label use of oxcarbazepine through an observational study with retrospective data collection. Data were obtained from four hospitals in Yogyakarta, namely Dr. Sardjito Hospital, UGM Hospital, PKU Muhammadiyah Hospital and Bethesda Hospital. Off-label use of oxcarbazepine was identified based on official registration by NA-DFC Indonesia. The results of this study showed that the use of oxcarbazepine in 2014 was 224 prescriptions, which 117 (52.68%) was off-label. Most off-label indications according to ICD-10 were cephalgia 48 (41.03%), followed by trigeminal neuralgia 35 (29.91%), stroke 6 (5.13%) and others 29 (23.93%). From these study, the off-label use of oxcarbazepine was mostly in the cases of neuropathic pain.
IMPACT OF CISPLATIN BASE CHEMOTERAPY ON QUALITY OF LIFE IN INDONESIAN PATIENTS WITH CERVICAL CANCER Suwendar Suwendar; Achmad Fudholi; Tri Murti Andayani; Herri S. Sastramihardja
UNEJ e-Proceeding Proceeding of 1st International Conference on Medicine and Health Sciences (ICMHS)
Publisher : UPT Penerbitan Universitas Jember

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Cervical cancer is the most common malignantcancer of the female reproductive organs and affectsthem for a long period of time. If someone weresuffering from cervical cancer, then the quality of lifewill decline. This have been proven by research incancer patients in Dr. Sardjito Hospital includingcervical cancer [Perwitasari et al, 2011]. Not only theeffect of cervical cancer, the choice of chemotherapyregiment will also affect the quality of life(humanistic outcome) of the patients. There are avariety of chemotherapy regimens for cervicalcancer. Cisplatin-based chemotherapy regimen isrecommended by the NCCN (NationalComprehensive Cancer Network) and the Ministry ofHealth of Republic of Indonesia. Neverthelesshumanistic outcome research of these regimens arestill lacking. This study aims to evaluate the quality oflife of cervical cancer patients in Dr. Hasan SadikinHospital Bandung were treated with cisplatin basechemoterapy using the EQ-5D questionnaire.
Hubungan antara Efektivitas Hemodialisis dengan Kualitas Hidup Pasien Penyakit Ginjal Kronis di Yogyakarta Liliany Fatonah; Tri Murti Andayani; Nanang Munif Yasin
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 8 No. 1 (2021): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v8i12021.22-28

Abstract

Pendahuluan: Pasien Penyakit Ginjal Kronis (PGK) dengan hemodialisis (HD) memiliki kualitas hidup yang rendah. Hal ini dapat dipengaruhi oleh efektivitas HD. Nilai adekuasi HD yang disarankan oleh kementrian kesehatan RI untuk pasien HD dengan frekuensi dua kali seminggu yaitu ≥ 1,8. Meskipun demikian, di Indonesia mayoritas pasien menjalani HD dengan adekuasi HD < 1,8. Tujuan: Penelitian ini bertujuan untuk mengetahui hubungan antara efektivitas HD terhadap kualitas hidup pasien PGK dengan HD. Metode: Penelitian ini meggunakan rancangan cross sectional dengan teknik pengambilan sampel convenience sampling. Penelitian dilakukan di RSUP Dr Sardjito dan RS Akademik UGM pada bulan Januari hingga Maret 2020. Data primer yang digunakan yaitu kuesioner Kidney Disease Quality of Life Short Form-36 (KDQoL-SF36). Data sekunder yaitu rekam medis untuk mengumpulkan parameter efektivitas meliputi durasi HD tiap sesi, adekuasi HD (Kt/V) dan kecepatan aliran darah (Qb). Pengaruh efektivitas HD terhadap skor kualitas hidup dianalisis menggunakan independent sample t-test dan one-way ANOVA. Regresi linier berganda digunakan untuk menentukan prediktor utama dari kualitas hidup. Hasil: Diperoleh 109 pasien dengan skor rata-rata kualitas hidup 72,10 ± 11,58. Peningkatan durasi HD tiap sesi, adekuai HD dan kecepatan aliran darah berpengaruh signifikan terhadap peningkatan skor kualitas hidup (p < 0,05). Hasil analisis regresi linear berganda memaparkan bahwa penghasilan (p = 0,019), komorbid (p = 0,054), adekuasi HD (p = 0,029), dan juga kecepatan aliran darah (p = 0,006) merupakan prediktor kualitas hidup. Kesimpulan: Skor kualitas hidup pasien PGK dipengaruhi secara signifikan oleh durasi HD tiap sesi, adekuasi HD dan kecepatan aliran darah.
Analisis Faktor Klinik terhadap Kualitas Hidup Pasien Hemodialisis di RSUD dr. Loekmono Hadi Kudus Nafiah Adiningrum; Tri Murti Andayani; Susi Ari Kristina
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 8 No. 1 (2021): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v8i12021.29-37

Abstract

Pendahuluan: Penyakit ginjal kronik (PGK) dan hemodialisis berdampak negatif terhadap kualitas hidup pasien. Penilaian HRQoL penting dilakukan sebagai evaluasi terhadap kualitas layanan kesehatan dan efektivitas terapi. Tujuan: Untuk menilai status HRQoL pasien dan mengetahui faktor klinik yang berpengaruh terhadap kualitas hidup pasien hemodialisis di RSUD dr. Loekmono Hadi. Metode: Cross sectional dengan teknik total sampling pada pasien hemodialisis rutin yang memenuhi kriteria inklusi. Data sosiodemografi dan faktor klinik yang digunakan yaitu komorbid, durasi menjalani hemodialisis, kadar hemoglobin, ureum, dan kreatinin diperoleh dari rekam medik, sedangkan data kualitas hidup dinilai menggunakan kuesioner KDQoL-SF36 yang terdiri dari tiga domain. Gambaran kualitas hidup berdasarkan karakteristik sosiodemografi dianalisis menggunakan Independent sample t-test atau Mann-whitney test dan one-way ANOVA atau Kruskal-walis test. Analisis faktor klinik yang berpengaruh terhadap kualitas hidup menggunakan koefisien korelasi Spearman dan regresi logistik. Hasil: Skor rata-rata kualitas hidup pada 60 subjek penelitian sebesar 63,20 ± 17,05, sedangkan skor untuk domain penyakit ginjal, kesehatan fisik dan mental adalah 74,52 ± 9,83; 47,41 ± 25,09 dan 67,68±20,10. Faktor klinik berkorelasi lemah terhadap rata-rata skor domain kualitas hidup kecuali pada variabel durasi menjalani hemodialisis terhadap domain kesehatan fisik (r = 0,319). Analisis regresi logistik menunjukkan tidak terdapat faktor klinik yang secara signifikan paling berpengaruh terhadap kualitas hidup pasien (p > 0,05). Kesimpulan: Hasil pengukuran klinik merupakan informasi penting bagi dokter untuk melihat luaran terapi, namun parameter tersebut berkorelasi lemah terhadap HRQoL. Penilaian HRQoL diperlukan sebagai ukuran kecukupan dialisis dan kolaborasi tenaga kesehatan untuk meningkatkan HRQoL pasien.
Faktor-Faktor yang Berhubungan dengan Kualitas Hidup Pasien Penyakit Ginjal Kronis yang Menjalani Hemodialisis Renni Simorangkir; Tri Murti Andayani; Chairun Wiedyaningsih
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 8 No. 1 (2021): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v8i12021.83-90

Abstract

Pendahuluan: Hemodialisis (HD) merupakan salah satu terapi pengganti fungsi ginjal pada pasien penyakit ginjal kronis (PGK) yang dapat mengurangi morbiditas dan mortalitas, namun terapi HD dapat menimbulkan munculnya berbagai komplikasi yang dapat memengaruhi kualitas hidup pasien. Tujuan: Menganalisis faktor sosiodemografi dan faktor klinis yang berhubungan dengan kualitas hidup pasien PGK yang menjalani HD. Metode: Rancangan penelitian yang digunakan pada penelitian ini adalah cross sectional dengan melibatkan 130 pasien yang menjalani hemodialisis selama periode bulan Februari-April 2020 dengan kriteria inklusi pasien berusia ≥ 18 tahun, menjalani hemodialisis selama ≥ 3 bulan dan kriteria eksklusi pasien dalam kondisi kritis. Pengambilan data dilakukan dengan wawancara langsung dan melihat rekam medis pasien. Kualitas hidup diukur menggunakan kuesioner Kidney Disease Quality of Life-Short Form-36 (KDQOL-SF36). Data pada domain kesehatan fisik, kesehatan mental dan skor KDQOL-SF36 dianalisis menggunakan analisis regresi berganda-dummy. Hasil: Rata-rata usia responden penelitian adalah 49,6 ± 13,1 tahun, jumlah resep obat kronis 5,5 ± 1,7 jenis obat. Rata-rata skor KDQOL adalah 71,4 ± 10,1; kesehatan fisik 61,4 ± 20,4 dan kesehatan mental 81,2 ± 15,7. Faktor sosiodemografi yang memengaruhi kualitas hidup adalah usia (p = 0,000) dan tingkat penghasilan (p = 0,024) pada domain kesehatan fisik dan usia (p = 0,010), pada skor KDQOL (p = 0,010), untuk faktor klinis adalah jumlah peresepan (p = 0,010), dan komorbiditas (p = 0,007), lalu pada domain kesehatan fisik dan jumlah peresepan (p = 0,016) skor KDQOL. Kesimpulan: Terdapat hubungan antara faktor sosiodemografi dan klinis yakni faktor usia, tingkat penghasilan, komorbiditas DM dan jumlah peresepan obat kronis terhadap kualitas hidup pasien PGK yang menjalani HD (p < 0,05).
Analisis Faktor-Faktor Klinik yang Mempengaruhi Kualitas Hidup Pasien Katarak di Rumah Sakit Dr. YAP, Yogyakarta Rizky Hidayaturahmah; Tri Murti Andayani; Susi Ari Kristina
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 8 No. 3 (2021): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v8i32021.207-216

Abstract

Pendahuluan: Katarak merupakan keadaan dimana lensa mata menjadi keruh. Kondisi tersebut menyebabkan terjadinya penurunan akan kualitas hidup pasien, Penurunan kualitas hidup pasien katarak tidak hanya disebabkan oleh faktor sosiodemografi (usia, pendidikan, pengerjaan, penghasilan, jenis kelamin) tetapi juga adanya faktor klinik (mata yang mengalami katarak, lama terjadinya katarak, visus mata dan adanya komobid diabetes mellitus). Tujuan: Untuk menganalisis faktor-faktor klinik yang mempengaruhi kualitas hidup pasien katarak di Rumah Sakit Dr.YAP Yogyakarta. Metode: Desain penelitian yang digunakan pada penelitian ini adalah observasional analitik dengan rancangan Cross Sectional. Instrumen yang digunakan adalah Short Form-6 Dimension (SF-6D) versi Indonesia. Sampel penelitian adalah 464 pasien katarak di Rumah Sakit Dr.YAP Yogyakarta yang melakukan kontrol pada bulan Juni 2019–Januari 2020. Data kemudian dianalisa statistik menggunakan uji Mann-Whitney   dan uji Kruskal-Wallis untuk melihat apakah terdapat perbedaan yang signifikan antara variabel penelitian dan nilai utilitas. Hasil: Hasil penelitian yang dilakukan terhadap 464 responden dengan rata-rata usia  63 tahun dengan rata-rata nilai utilitas adalah 0,759. Domain yang banyak terdapat masalah kesehatan dari kuesioner SF-6D adalah domain rasa sakit (76,1%), dilanjutkan dengan domain kesehatan mental (73,3%) dan domain fungsi fisik (64,0). Hasil uji statistik didapatkan bahwa nilai p-value kualitas hidup pada faktor klinik mata yang mengalami katarak (0,000), visus mata (0,000) dan komorbid (0,031) menunjukkan perbedaan yang signifikan, sedangkan untuk faktor lama katarak tidak meunjukkan perbedaan yang signifikan (0,600). Kesimpulan: Faktor klinik yang mempengaruhi kualitas hidup pasien katarak adalah adanya komorbid, mata yang mengalami katarak dan visus mata.
The Short Form-6 Dimension (SF-6D) Validity and Reliability in Hemodialysis Patients Anisa Zulfa Fatihah; Tri Murti Andayani; Nanang Munif Yasin
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 8 No. 2 (2021): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v8i22021.150-155

Abstract

Background: Quality of life becomes an important parameter that is needed for assessing the clinical outcome of patients undergoing long-term therapy for chronic diseases, such as chronic kidney failure. Short Form-6 Dimension (SF-6D) is one of the generic instruments that can be used to assess health-related quality of life (HRQOL). The psychometric properties SF-6D test in hemodialysis patients in Indonesia has never been conducted. Objective: Aimed to evaluate the reliability and validity of SF-6D questionnaire in Indonesian version in patients with chronic kidney failure. Methods: This is an observational study with a cross-sectional design involving 117 patients who meet the inclusion and exclusion criteria in the hemodialysis unit in Dr. Sardjito Central General Hospital and UGM Academic Hospital Yogyakarta. Results: The SF-6D questionnaire has good internal consistency, as seen in Cronbach's alpha value of 0.771. In this study, the ceiling effect test showed 6.8% (< 15%). The measurement of convergent validity was carried out using Spearman rho to analyze the correlation of the questionnaires and see its correlation with other instruments (KDQOL-SF36). Based on the research, the correlation coefficient value of 0.768 (> 0.75) indicates very good result for a strong correlation. The SF-6D instrument was able to distinguish the quality of life with a significant value (p < 0.05) in age, occupation, and comorbid groups. Conclusion: SF-6D questionnaire is valid and reliable, so it can be used to measure the HRQOL of hemodialysis patients. The mean SF-6D utility score of hemodialysis patients is high (0.7975 ± 0.1488).
Co-Authors . Inayati A.M Wara Kusharwanti Abdul Khodir Jaelani Abdul Mahmud Yumassik Achmad Fudholi Achmad Fudholi Achmad Fudholi Achmad Fudholi admaja, wika Agung Endro Nugroho Agustini, Tiara Tri Ahmad H. Asdie Ahmad Suriyadi Muslim Ahmad, Irfan Aisyah, Noor Akuba, Jusnita Ali Ghufron Mukti Ali Gufron Mukti Amalia Amalia Amalia Amalia Amalia Amalia Ambar Yunita Nugraheni Amelia Lorensia Anak Agung Gede Sugianthara Ani Pahriyani Anisa Zulfa Fatihah Anna Wahyuni Widayanti Anni Anni, Anni Aqnes Budiarti Ari Dwidayati Arief Nurrochmad Arini, Yovita Dwi Arissa Dwiningrum Artemisia, Rahma Astuti, Rini Budi Atsna, Zafria Avrilya Iqoranny Susilo Ayuning Siwi, Mayang Aditya Azalea, Metty Bekti Meilani Nurcahya Belinda Arbitya Dewi Candra Eka Puspitasari Candraningrat, I Dewa Agung Ayu Diva Cecep Kusmana Chairun W Chairun W Chairun Wiedyaningsih Chinthia Sari Yusriana Desy Purnamasari Dewi, Mahmud Carica dharmika wijaya sakti Dhiyan Kusumawati Didik Setiawan Dina Fatma Alia Dinaryanti, Pratiwi Dini Okyaviani Dini, Intan Rahmania Eka Diyan Ajeng Rossetyowati Diyan Ajeng Rossetyowati Djoko Wahyono Djoko Wahyono Dwiningrum, Arissa Dyah, Ria Istamining Eka Kartika Untari Eka Tri Wulandari Elsa Zhenita, Albela Endang Suparniati Endang Suparniati, Endang Endang Yuniarti Endang Yuniarti erna prasetyaningrum Etikasari, Ria Farida Munawaroh Farida, Yeni Ferdinan Jalung Ferdinan Jalung Ferdy Firmansyah Fidiawan, Arie Firda Ridhayani Fita Rahmawati Fita Rahmawati Fitri, Elny Fredie Irijanto Fredie Irijanto Fridly Manawan Gita Mayasari Gunawan Pamudji Widodo Hafizah, Ilmi Nur Halimah Hayul Halimah Hayul Handi Mukti Fahrizal Handi Mukti Fahrizal Haninditya, Beta Hari Kusnanto Hari Kusnanto Haris, Restu Nur Hasanah Herri S. Sastramihardja Hilmy Irsyadi Hanif Hutahaean, Amsaline Vingky I Dewa Putu Pramantara I Dewa Putu Pramantara I Dewa Putu Pramantara S Ibrahim Arifin Ika Alfinnisa Majida Ika Norcahyanti Ika Purwidyaningrum Ika Puspita Sari IKA PUSPITA SARI Ika Puspitasari Ika Puspitasari Ika Puspitasari Ika Trisnawati Ika Trisnawati, Ika Ikakusumawati, Novita Dhewi Imaniar Noor Faridah Imaniar Noor Faridah Inayati Inayati Inayati, Inayati Indriyati Hadi Sulistyaningrum Ingenida Hadning Intan Rahmania Eka Dini Irfanianta Arif Setyawan Irnayanti Irnayanti Irnayanti, Irnayanti Ivanka, Luna Iwan Dwiprahasto Iwan Dwiprahasto Jaelani, Abdul Khodir Jaelani, Abdul Khodir Jaelani, Abdul Qadir Jarir At Thobari Jason Merari Peranginangin Joko Sunowo Kartika Widayati Taroeno Hariadi Kusharwanti, A.M Wara Kusumawati, Dhiyan L. Endang Budiarti, L. Endang Larasati, Laksmy Anggun Lering, Maria Nona Adriani Liliany Fatonah Lingga Ikaditya Lingga Ikaditya, Lingga Listyana, Yanverty Idda Lukman Hakim Luthfan Budi Purnomo Magistasari, Dewi Makmur, Rahmat Maranatha, Daniel Mariana Wahyudi Mariska Sri Harlianti Mariska Sri Harlianti Marlina, Ni Ketut Martodiharjo, Suwaldi Maulidia, Shofia Siza Mawaqit Makani Maya Arfania Mayasari, Gita Megawati Parmasari Metty Azalea Milda Rianty Lakoan Milda Rianty Lakoan Mohamed Izham Mohamed Ibrahim Mohammad Robikhul Ikhsan Mpila, Deby Afriani Mufarrihah Mufarrihah Mufarrihah, Mufarrihah Mukhamad Najib Mukti, Ali Gufron Mulyani, Risya Munawaroh, Farida Murni, Siti Olega Adawiyah Muslimah Muslimah Mustofa Mustofa Nafiah Adiningrum Nanang Munif Yasin Nanang Munif Yasin Natalia Gilarsih Natalia Gilarsih Nawang Wulan Nago Pitasari Neneng Ratnasari Novena Adi Yuhara Novia Ariani Dewi Novianti, Feby Galuh Nur Rasdianah Nurcahya, Bekti Meilani Nurifahmi, Rahmaningtyas Nuring Novita Kusumawati Nurul Adzkia Ghearizky Nurul Ambianti Nurul Hikmah Nurul Latifah Nurul Qiyaam, Nurul Nurul Safitri Nuryanti, Tety Nutrisia Aquariushinta Sayuti, Nutrisia Aquariushinta Octavia, Mega Oetari Oetari Oetari Oetari Okke Putri Shera Oktaviani, Devi Okti Ratna Mafruhah Pahriyani, Ani Pamungkas, Kumbang Nirbhaya Pande Made Desy Ratnasari Parmasari, Megawati Partini Partini Partini Partini, Partini Pramana, Facetha Intan Pratiwi, Woro Rukmi Primadiamanti, Annisa Purnamasari, Vina Purnomo, Luthfan Budi Purwoko, Agus Putri Dina Mahera Laily Rahajeng, Bangunawati Rahayu, Asri Rahma, Nazulanita Rahmawati, Anindya Rahmawati, Fita Rahmawati, Fita Ramadhani, Syahrizal Rastiti, Liza Ratnasari, Pande Made Desy Renni Simorangkir Ria Etikasari Ria Istamining Dyah Rina Triasih Riskayanti Riswaka Sudjaswadi Riyanta Aribawa Rizaldy Pinzon Rizaldy T Pinzon Rizka Humardewayanti Asdie Rizky Danang Susetyo Rizky Hidayaturahmah Rokhman, Rifqi Rukminingsih, Fef Ryan Astaruddin S, I Dewa Putu Pramantara Safnurbaiti, Dwi Putri Saharuddin, Tria Saputra Sammulia, Suci Fitriani Sampurno Sampurno Sampurno Sampurno Sampurno, Sampurno Santi Andriani Saputra, Andy Kurniawan Saputri, Erlika Sari, Maya Dwi Wulan Sari, Rafika Mutia Sarifudin, Barbara Azalya Satibi Satibi Satibi Satibi Satibi Satibi Satibi Satibi Selamet, Ni Made Dwi Antika Setiyaningsih, Hermawati Setyawan, Irfanianta Arif Simanullang, Raymon Siradjuddin, Ammar Sri Haryanti Starlista, Viva Sudewi Mukaromah Khoirunnisa Suffiana, Yunita Sugiyanto - Sugiyanto Sugiyanto Sukengtyas, Dyah Atmi Tri Sulistiawaty, Endang Sunarti Sunarti Supanji, Supanji Susi Ari Kristina Susi Ari Kristina Suwendar Suwendar Syaiful Katadi Tety Nuryanti Titik Nuryastuti Titik Sunarni Tri Wijayanti Tria Saputra Saharuddin Tuangrat Phodha Umi Athijah Venanti, Bernadeta Setyo Vo Quang Trung widi astuti r Widiastuti Widiastuti Willi Wahyu Timur Winarni Winarni Wirawan Adikusuma Wulandari, Aprilla Ayu Yance Anas Yeni Farida Yopi Rikmasari, Yopi Yovita Dwi Arini Yusriana, Chinthia Sari Zullies Ikawati ZULLIES IKAWATI Zullies Ikawati Zullies Ikawati